logo

For the Inventor, By the Inventor

Las Vegas, NV, United States of America

Alderbio Holdings LLC


USPTO Granted Patents = 98



Forward Citations = 1,044

Loading Chart...
Loading Chart...

102 inventors (with patents filed for the assignee):

goldMedal John A Latham (69 out of 122 patents)

silverMedal Jeffrey T L Smith (67 out of 95 patents)

bronzeMedal Leon F Garcia-Martinez (59 out of 88 patents)

4.  Benjamin H Dutzar (44 out of 70 patents)

5.  Ethan Wayne Ojala (37 out of 63 patents)

6.  Brian Robert Kovacevich (36 out of 65 patents)

7.  Katie Olson Anderson (28 out of 38 patents)

8.  Anne Elisabeth Carvalho Jensen (18 out of 21 patents)

9.  Patricia Dianne McNeill (16 out of 45 patents)

10.  Mark Litton (16 out of 20 patents)

11.  Randall Schatzman (15 out of 18 patents)

12.  Danielle Mitchell (14 out of 25 patents)

13.  Jens J Billgren (12 out of 28 patents)

14.  Pei Fan (11 out of 32 patents)

15.  Andrew Lawrence Feldhaus (11 out of 28 patents)


Core Competencies:
Anti-IL-6 Antibodies
Anti-CGRP Compositions
Antagonists of IL-6
Anti-NGF Compositions
Humanized Antibodies
Polypeptide Synthesis
Antibody Production
Therapeutic Antibodies

98 patents:

1. 10858424 - Anti-IL-6 antibodies for the treatment of arthritis (2020-12-08),
2. 10765746 - Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels (2020-09-08),
3. 10759853 - Antibodies to IL-6 and use thereof (2020-09-01),
4. 10640560 - Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and /or fever (2020-05-05),
5. 10550180 - Anti-ACTH antibodies and use thereof (2020-02-04),
6. 10544214 - Humanized anti-ACTH antibodies and use thereof (2020-01-28),
7. 10533048 - Anti-CGRP compositions and use thereof (2020-01-14),
8. 10471143 - Antagonists of IL-6 to raise albumin and/or lower CRP (2019-11-12),
9. 10457727 - Methods of preventing inflammation and treating pain using anti-NGF compositions (2019-10-29),
10. 10391169 - Method of treating allergic asthma with antibodies to IL-6 (2019-08-27),
11. 10344086 - Antibodies to IL-6 and use thereof (2019-07-09),
12. 10344083 - Anti-NGF compositions and use thereof (2019-07-09),
13. 10266587 - Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers (2019-04-23),
14. 10259885 - Anti-PCSK9 antibodies and use thereof (2019-04-16),
15. 10259883 - Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy (2019-04-16),
ALDERBIO HOLDINGS LLC is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic antibodies. With a commitment to improving patient lives, ALDERBIO develops innovative antibody-based treatments for various diseases, including migraine prevention and autoimmune disorders.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
98 Patents

#17 in Las Vegas, NV

#26 in Nevada

#3,714 in US

#7,675 in the World

...
Las Vegas, NV, United States of America

Alderbio Holdings LLC

Forward Citations = 1,044

102 inventors:

goldMedal John A Latham (69 out of 122 patents)

silverMedal Jeffrey T L Smith (67 out of 95 patents)

bronzeMedal Leon F Garcia-Martinez (59 out of 88 patents)

4.  Benjamin H Dutzar (44 out of 70 patents)

5.  Ethan Wayne Ojala (37 out of 63 patents)

Please report any incorrect information to support@idiyas.com
Loading…